I have a Question hopefully someone can thoroughly
Post# of 148181
Can someone please explain the differences in the effect of Leronlimab vs Selzentry (Maraviroc), besides that of a longer half-life in the former. Obviously, Leronlimab is a monoclonal antibody base. How do their potency relate? The selectivity of each?
Thanks for your input